WHO ICTRP trial
Evaluation of different doses of triamcinolone acetonide in inhibiting anterior…
ChiCTR-TRC-12002314 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TRC-12002314 |
|---|---|
| Public title | Evaluation of different doses of triamcinolone acetonide in inhibiting anterior uveitis after combined phacoemulsification and trabeculectomy |
| Scientific title | Evaluation of different doses of triamcinolone acetonide in inhibiting anterior uveitis after combined phacoemulsification and trabeculectomy |
| Primary sponsor | Beijing Shijitan Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Pilot study |
| Countries | China |
| Conditions | Glaucoma |
| Interventions | Triamcinolone acetonide 0.5:intracameral triamcinolone acetonide 0.5mg in combined phacoemulsification and trabeculectomy;Triamcinolone acetonide 1.0:intracameral triamcinolone acetonide 1.0mg in combined phacoemulsification and… |
| Registration date | Jun 29, 2012 |
| Target size | Triamcinolone acetonide 0.5:30;Triamcinolone acetonide 1.0:30;Triamcinolone… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: